As of 2025-03-25, the Relative Valuation of Pharmala Biotech Holdings Inc (MDMA.CN) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.20 CAD, the upside of Pharmala Biotech Holdings Inc based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |